See Eligibility Criteria And Search Trial Site Locations For The FIERCE-HN Clinical Trial.
Explore POTELIGEO® As A Treatment Option That May Be Right For Your Patients. Watch A Helpful Mechanism Of Action Video To Understand How POTELIGEO® Works - Learn More.
Visit The Official Patient Website To See If POTELIGEO® Is The Right Treatment For You. Review The POTELIGEO® Infusion Schedule To Learn How It Will Be...
Mogamulizumab
Drug
>
Mogamulizumab, sold under the brand name Poteligeo, is a humanized, afucosylated monoclonal antibody targeting CC chemokine receptor 4. The U.S. Food and Drug Administration approved it in August 2018 for treatment of relapsed or refractory... Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L01FX09 (WHO)
License data: US DailyMed: Mogamulizumab
Pronunciation: moe gam" ue liz' ue mab